chr11-77156069-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000260.4(MYO7A):c.448C>T(p.Arg150Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,461,548 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R150R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000260.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.448C>T | p.Arg150Ter | stop_gained | 5/49 | ENST00000409709.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.448C>T | p.Arg150Ter | stop_gained | 5/49 | 1 | NM_000260.4 | ||
MYO7A | ENST00000458637.6 | c.448C>T | p.Arg150Ter | stop_gained | 5/49 | 1 | P1 | ||
MYO7A | ENST00000409619.6 | c.415C>T | p.Arg139Ter | stop_gained | 6/50 | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461548Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727028
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 20, 2023 | This sequence change creates a premature translational stop signal (p.Arg150*) in the MYO7A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO7A are known to be pathogenic (PMID: 8900236, 25404053). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with autosomal recessive Usher syndrome (PMID: 7870171, 28451532). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 11847). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 20, 2020 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 16470552, 28451532, 31479088, 7568224, 7870171, 9002678, 20613545, 31054281, 33576163) - |
Usher syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 13, 2020 | The p.Arg150X variant in MYO7A has been previously reported in five individuals with Usher syndrome and one individual with sensorineural hearing loss who were either homozygous for the variant or harbored a second pathogenic MYO7A variant in trans (Jaijo 2006 PMID:16470552, Kimberling 2010 PMID:20613545, Nakanishi 2010 PMID:20844544, Asgharzade 2017 PMID:28451532, Ivanova 2018 PMID:30358468, Gao 2019 PMID:31054281, LMM unpublished data). It is absent from large population studies. This nonsense variant leads to a premature termination codon at position 150, which is predicted to lead to a truncated or absent protein. Loss of function of the MYO7A gene is an established disease mechanism in autosomal recessive Usher syndrome. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Usher syndrome. ACMG/AMP Criteria applied: PVS1, PM2, PM3, PP4. - |
Usher syndrome type 1B Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 10, 1995 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at